What does cygnus — asset impairments mean?

Reflects non-cash charges recognized when the carrying value of long-lived assets within the Biologics Safety Testing segment exceeds their recoverable amount. This metric indicates potential declines in the value of equipment, technology, or intangible assets. It serves as a critical indicator of asset health and potential future operational challenges.

Maravai LifeSciences Holdings, Inc. (MRVI) Cygnus — Asset Impairments

Screener

Other segment segments

TriLink

$605K-77.6%

Corporate

$0-100%

Similar metrics at other companies

ANDEAgribusiness — Asset impairment

$3.7M—

ANDERenewables — Asset impairment

$850K—

SUIMH / RV — Asset Impairment Charges

$14.1M—

SXCDomestic Coke — Long-lived asset impairment

$90.1M—

RNGRReportable Segment — Impairment of assets

$0—

INSGReportable Segment — Right-of-use asset impairment

$0-100%

Other financials

Income statement

See full

Revenue$51.4M+8.5%

Gross profit$20.7M+166%

Operating income-$15.1M+77.2%

Net income-$12.4M+68.6%

EPS (diluted)-$0.08+70.4%

Balance sheet

See full

Cash & equivalents$70.6M-73.8%

Total debt$176.7M-52.4%

Total equity$204.6M-23.0%

Total assets$603.7M-32.7%

Cash flow

See full

Operating cash flow$4.0M+139%

CapEx$370.0K-87.1%

Free cash flow$3.6M+128%

Valuation

See full

Market cap$918.96M+210%

Enterprise value$1.03B+158%

P/S4.4×+3.1×

Profitability

See full

Gross margin34.9%+4.4pp

Operating margin-56.1%-21.3pp

Net margin-37.1%-13.6pp

FCF margin-17.2%—

Returns & leverage

See full

Return on equity-32.9%-9.4pp

Debt / equity0.9×-0.5×

Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026. Open the filing →

Filed: Aug 7, 2026, 4:03 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001823239-26-000059

FAQ

What is Maravai LifeSciences Holdings, Inc.'s cygnus — asset impairments?: Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — asset impairments of $0 in Q2 2026.
What does cygnus — asset impairments mean?: Reflects non-cash charges recognized when the carrying value of long-lived assets within the Biologics Safety Testing segment exceeds their recoverable amount. This metric indicates potential declines in the value of equipment, technology, or intangible assets. It serves as a critical indicator of asset health and potential future operational challenges.